FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean‐Baptiste Bachet, Alice C. Wei et al.|New England Journal of Medicine|2018Cited by 2.8k
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Gabriele Luppi, Jean‐Frédéric Blanc et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 61